Acme United Reports Q2 2026 Earnings with Strong Sales Growth
Acme United Corporation reported strong second-quarter performance in fiscal year 2026, driven by the acquisition of MyMedic and increased sales across its product lines. Net sales grew by 16%, primarily due to a surge in U.S. first aid products and successful promotions for Westcott cutting tools after previous disruptions from tariffs. Gross margin expanded to 42.6% as high-margin direct-to-consumer operations of MyMedic contributed significantly. The company is actively integrating the acquisition through cost reductions, freight consolidation, and leveraging sourcing teams. European growth reached 19%, despite inflationary pressures, thanks to new product lines. Looking ahead, management expects continued margin expansion over the next two quarters as high-tariff inventory is replaced with lower-cost products. MyMedic's profitability is expected in Q4 due to seasonal demand and FSA spending.
Tickers: $ACU
Topics: acquisition_integration gross_margin_expansion sales_growth supply_chain_strategy